Skip to main content
. 2020 Mar 11;10(3):151. doi: 10.3390/diagnostics10030151
AR Androgen receptor
AR-V7 AR splice variant 7
Enz Enzalutamide
Abi Abiraterone
CTC Circulating tumor cells
DTX Docetaxel
CBZ Cabazitaxel
RT-PCR Real-time polymerase chain reaction
cDNA Complementary DNA
CRPC Castration-resistant prostate cancer
nmCRPC Non-metastatic CRPC
mCRPC Metastatic CRPC
CTC Circulating tumor cells
mRNA Messenger ribonucleic acid
ALP Alkaline phosphatase
LDH Lactate dehydrogenase
Alb Albumin
Hb Hemoglobin
GS Gleason score
EDTA Ethylene-diamine-tetra-acetic acid
RT Reverse transcription
OS Overall survival
PSA Prostate-specific antigen
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
EOD Extent of disease
PBMC Peripheral Blood Mononuclear Cells
JHU Johns Hopkins Hospital
PCWG Prostate Cancer Clinical Trials Working Group
RBC red blood cell
BSA Bovine Serum Albumin
BSA Bovine Serum Albumin
PBS Phosphate-Buffered Saline
GAPDH glyceraldehyde-3-phosphate dehydrogenase
Ct Threshold Cycle
SD Standard Deviation
HR Hezard Ratio
PSMA Prostate Specific Membrane Antigen
EGFR Epidermal growth factor receptor
DAPI 4’,6-diamidino-2-phenylindole
FACS fluorescence-activated cell sorting